Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: Case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2)

Journal of Surgical Oncology

Volumn 67, Issue 2, 1998, Pages 121-125

  Kaplan, Mark J ^a   Somers, Robert G ^a   Greenberg, Richard H ^a   Ackler, Joann ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; MeSH words; Photochemotherapy; Photosensitizing agents

Indexed keywords

PURPURIN;

ADENOCARCINOMA; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CASE REPORT; HUMAN; LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN METASTASIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; FEMALE; HUMANS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PORPHYRINS; RADIATION-SENSITIZING AGENTS; SKIN NEOPLASMS; SUBMANDIBULAR GLAND NEOPLASMS;

EID: 0031888789     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199802)67:2<121::AID-JSO9>3.0.CO;2-C     Document Type: Article

References (15)

1. Dougherty TJ, Marcus SL: Photodynamic therapy. Eur J Cancer 1992;28A:1734-1742.
2. Pass HI: Photodynamic therapy in oncology: Mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-456.
3. Moan J: Properties for optimal PDT sensitizers. J Photochem Photobiol 1990;5:521-524.
4. Tochner Z, Mitchell JB, Smith P, et al.: Photodynamic therapy of ascites tumours within the peritoneal cavity. Br J Cancer 1986; 53:733-736.
5. Canti G, Franco P, Marelli O, et al.: Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210). Cancer Res 1984;44:1551-1556.
6. Weishaupt KR, Gomer CJ, Dougherty TJ: Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-2329.
7. Reed MW, Schuschke DA, Ackermann DM, et al.: The response of the rat urinary bladder microcirculation to photodynamic therapy. J Urol 1989;142:865-868.
8. Wieman TJ, Mang TS, Fingar VH, et al.: Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery 1988; 104:512-517.
9. Ben-Hur E, Orenstein A: The endothelium and red blood cells as potential targets in PDT-induced vascular stasis. Int J Radiat Biol 1991;60:293-301.
10. Hilf R, Smail DB, Murant RS, et al.: Hematoporphyrin derivativeinduced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230AC mammary adenocarcinomas of rats. Cancer Res 1984;44:1483-1488.
11. Hilf R, Murant RS, Narayanan U, Gibson SL: Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R3230AC mammary tumors. Cancer Res 1986;46:211-217.
12. Gibson SL, Murant RS, Chazen MD, et al.: In vitro photosensitization of tumour cell enzymes by photofrin II administered in vivo, Br J Cancer 1989;59:47-53.
13. Gibson SL, Murant RS, Hilf R: Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5′-nucleotidase, Na+K+-ATPase and Mg2+-ATPase in R3230AC mammary adenocarcinomas. Cancer Res 1988;48: 3360-3366.
14. Gomer CJ: Preclinical examination of 1st and 2nd generation photosensitizers used in photodynamic therapy. Photochem Photobiol 1991;54:1093-1107.
15. Kongshaug M, Moan J, Cheng LS, et al.: Binding of drugs to human plasma-proteins, exemplified by Sn (IV)-etiopurpurin dichloride delivered in Cremophor and DMSO. Int J Biochem 1993; 25:739-760.